Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Juno Therapeutics (JUNO) News Today

Juno Therapeutics logo
Shape Therapeutics CEO departs, interim named
Out of the lab and into the factory
EFTR eFFECTOR Therapeutics, Inc.
What we know about Jeff Bezos’ net worth
How Zelda Williams Found Humor in Trauma
Get Juno Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JUNO and its competitors with MarketBeat's FREE daily newsletter.

We recommended Nvidia in 2016, now we’re recommending this… (Ad)

The Pentagon has just made a critical $7.7 billion move. They're investing into one of the most controversial technologies the world has ever known… A technology I’m calling “The AI Keystone”, because without it, the AI industry is doomed.

Click here to watch his special investigative report into the controversial ‘AI Keystone’.

JUNO Media Mentions By Week

JUNO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

JUNO
News Sentiment

0.00

0.45

Average

News Sentiment

JUNO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

JUNO Articles
This Week

0

0

JUNO Articles
Average Week

Get Juno Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JUNO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:JUNO) was last updated on 11/6/2024 by MarketBeat.com Staff
From Our Partners